References
Blake GM, Zivanovic MA, Blaquiere RM, Fine DR, McEwan AJ, Ackery DM (1988) Strontium-89 therapy: measurement of absorbed dose to skeletal metastases. J Nucl Med 29:549–567
Erf LA, Lawrence JH (1941) Phosphorous metabolism in neoplastic tissues. Proc Soc Exp Biol Med 48:694–695
Firusian N, Mellin P, Schmidt CG (1976) Results of strontium-89 therapy in patients with carcinoma of the prostate and incurable pain from bone metastases: a preliminary report. J Urol 118:764–768
Holmes RA (1992) [135Sm]EDTMP: a potential therapy for bone cancer pain. Semin Nucl Med 22:41–45
Kaplan E, Fels IG, Kotiowski BR, Greco J, Walsh WS (1960) Therapy of carcinoma of the prostate metastatic to bone with 32p labelled condensed phosphate. J Nucl Med 1:1–13
Lewington VJ, McEwan AJ, Ackery DM, Bayly RJ, Keeling DH, MacLeod PM, Porter AT, Zivanovic MA (1991) A prospective, randomized double blind cross over study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone. Eur J Cancer 27:954–958
Lewington VJ, Boyer PJ, Dearnaly DP, Kirk D, Quilty PM, Yardley J, Zivanovic MA (1992)89Sr — an effective alernative to radiotherapy for prostatic metastases. Nucl Med Commun 13:211–212
Mauch Pm, Drew MA (1985) Treatment of metastable cancer to bone. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer principles and practice. Lippincott, Philadelphia, pp 2132–2141
Maxon HR, Deutsch EA, Thomms SR (1988) Re-186(Sr)HEDP for treatment of multiple metastatic foci in bone: human biodistribution and dosimetric studies. Radiology 166:501–507
Maxon HR, Schroder LE, Hertzberg VS, Thomas SR, Englaro EE, Samaratunga R, Smith H, Moulton JS, Williams CC, Ehrhardt GJ, Schneider HJ (1991) Re-186(Sn) HEDP for treatment of painful osseous metastases: result of a double blind crossover comparison with placebo. J Nucl Med 32:1877–1881
McEwan AJ, Porter AT, McGowan D, Amyotte G (1992) Adjuvant strontium-89 in prostate cancer: First report of the transCanada collaborative study. Eur J Nucl Med 19:608
Montebello JF and Harston-Eaton M (1989) The palliation of osseous metastases with32P or89Sr compared with external beam and hemibody radiotherapy: an historical perspective. Cancer Investigation 7:139–160
Robinson RG, Preston DF, Spicer JA, Baxter KG (1992) Radionuclide therapy of intractable bone pain: emphasis on strontium-89. Semin Nucl Med 22:28–32
Silberstein EB, Elgazzar AH, Kapilivsky A (1992) Phosphorus-32 radiopharmaceuticals for the treatment of painful osseous metastases. Semin Nucl Med 22:17–27
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McEwan, A.J.B. Pain palliation and nuclear medicine. Eur J Nucl Med 20, 1–3 (1993). https://doi.org/10.1007/BF02261237
Issue Date:
DOI: https://doi.org/10.1007/BF02261237